Page last updated: 2024-10-26

diethylcarbamazine and Bone Marrow Diseases

diethylcarbamazine has been researched along with Bone Marrow Diseases in 1 studies

Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.

Bone Marrow Diseases: Diseases involving the BONE MARROW.

Research Excerpts

ExcerptRelevanceReference
"The mechanism of action of diethylcarbamazine (DEC), an antifilarial drug effective against tropical pulmonary eosinophilia, remains controversial."7.76Inducible nitric oxide synthase/CD95L-dependent suppression of pulmonary and bone marrow eosinophilia by diethylcarbamazine. ( Barradas, M; de Luca, B; Dias, EP; E Silva, PM; Gardel, MA; Gaspar-Elsas, MI; Masid, D; Peixoto, CA; Queto, T; Vasconcelos, ZM; Xavier-Elsas, P, 2010)
"The mechanism of action of diethylcarbamazine (DEC), an antifilarial drug effective against tropical pulmonary eosinophilia, remains controversial."3.76Inducible nitric oxide synthase/CD95L-dependent suppression of pulmonary and bone marrow eosinophilia by diethylcarbamazine. ( Barradas, M; de Luca, B; Dias, EP; E Silva, PM; Gardel, MA; Gaspar-Elsas, MI; Masid, D; Peixoto, CA; Queto, T; Vasconcelos, ZM; Xavier-Elsas, P, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Queto, T1
Xavier-Elsas, P1
Gardel, MA1
de Luca, B1
Barradas, M1
Masid, D1
E Silva, PM1
Peixoto, CA1
Vasconcelos, ZM1
Dias, EP1
Gaspar-Elsas, MI1

Other Studies

1 other study available for diethylcarbamazine and Bone Marrow Diseases

ArticleYear
Inducible nitric oxide synthase/CD95L-dependent suppression of pulmonary and bone marrow eosinophilia by diethylcarbamazine.
    American journal of respiratory and critical care medicine, 2010, Mar-01, Volume: 181, Issue:5

    Topics: Airway Resistance; Animals; Bone Marrow Diseases; Bronchoconstrictor Agents; Diethylcarbamazine; Eos

2010